|
COPYRIGHT 2002 International Medical News Group
Those of us who treat people with psoriasis know the profound impact this disease can have on a patient's quality of life.
For patients with 10% or less body surface area affected, a topical preparation can be a safe, and convenient therapeutic option. To date, only one topical retinoid has been developed specifically for the management of psoriasis: tazarotene, marketed by Allergan under the trade name Tazorac. I would like to point out that although I have conducted studies of Tazorac for Allergan, I have no financial interest in the company
Because tazarotene is a retinoid, the U.S. Food...
Read the full article for free courtesy of your local library.
| 
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
